C-peptide is then cut out, ... Stevenson, research specialist Kylie Uyeda, graduate student Jessica San Juan and Ian Farran, undergraduate majoring in biochemistry and molecular biology. ...

C-peptide is a biomarker of insulin reserve and can be used to help identify patients incorrectly diagnosed with type 1 diabetes, potentially resulting in the reduction or cessation of insulin ...

Both treatment groups saw declines in C-peptide levels by 12 months, and mean area under the curve (AUC) for plasma C-peptide levels at 12 months—the study’s primary end point—was not ...

Recombinant human glutamic acid decarboxylase formulated with aluminum hydroxide may preserve C-peptide and improve HbA1c for people with type 1 diabetes carrying a specific genotype, according to ...

Whether improved glucose control with hybrid closed-loop therapy can preserve C-peptide secretion as compared with standard insulin therapy in persons with new-onset type 1 diabetes is unclear.In a ...

Biochemistry: Peptide 'fingerprint' enables earlier diagnosis of Alzheimer's disease. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2022 / 07 / 220720102517.htm.

Biochemistry: Peptide “fingerprint” enables earlier diagnosis of Alzheimer’s disease. Karlsruher Institut für Technologie (KIT) DOI 10.1002/adma.202110404. Keywords ...

Older children with newly diagnosed type 1 diabetes who received intensive diabetes management with automated insulin delivery had no difference in pancreatic C-peptide levels compared with ...